Low RECK Expression Is Part of the Cervical Carcinogenesis Mechanisms

Suellen Herbster1, Marina Trombetta-Lima2, Paulo Thiago de Souza-Santos3

  • 1Laboratory of Oncovirology, Department of Microbiology, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo 05508-900, Brazil.

Cancers
|June 2, 2021
PubMed

Insights

Reversion-inducing Cysteine-rich protein with Kazal motifs (RECK) suppresses human papillomavirus (HPV) cervical cancer. Increased RECK expression reduced tumor growth and improved survival, while its loss correlates with disease progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Human papillomavirus (HPV) infection is a primary cause of cervical cancer.
  • Matrix metalloproteinases (MMPs) and their regulators, like RECK, are implicated in cancer development.
  • RECK typically inhibits MMP activity and is often downregulated in human cancers.

Purpose of the Study:

  • To investigate the role of RECK in cervical carcinogenesis.
  • To analyze the impact of RECK overexpression on tumor growth, immune response, and molecular characteristics in vivo.
  • To assess RECK expression levels in clinical cervical cancer samples.

Main Methods:

  • Overexpression of RECK in cervical cancer cell lines.
  • In vivo tumor growth and survival studies in a mouse model.
  • Analysis of tumor cell viability, endothelial cell proliferation, collagenase activity, and immune cell infiltration.
  • Examination of RECK mRNA levels in patient-derived cervical lesions and correlation with disease progression and chemotherapy response.

Main Results:

  • RECK overexpression significantly delayed tumor growth and enhanced overall survival in vivo.
  • RECK-overexpressing tumors showed increased lymphoid-like inflammatory cells and reduced tumor and endothelial cell viability.
  • Lower RECK mRNA levels were associated with cervical lesion progression and poorer chemotherapy outcomes in patients.

Conclusions:

  • Increased RECK expression diminishes the tumorigenic potential of HPV-transformed cells.
  • RECK downregulation is a significant event in cervical cancer progression and is linked to clinical outcomes.

Related Concept Videos

Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.3K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.3K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.0K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.7K